ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2410

Report from the International Consortium of Health Outcome Measurement Hip and Knee Osteoarthritis Working Group: Consensus on an International Standard Set of Outcomes Measures for Patients with Hip or Knee Osteoarthritis.

Philip G. Conaghan1, Lyn March2, Ola Rolfson3, Stephanie Wissig4, Caleb Stowell5, Patricia D. Franklin6 and The ICHOM Working Group in Hip & Knee Osteoarthritis, 1University of Leeds & NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom, 2Department of Rheumatology, Northern Clinical School, Institute of Bone and Joint Research, Kolling Institute, University of Sydney & Department of Rheumatology, Royal North Shore Hospital, St Leonards, Sydney, Australia, 3Harris Orthopaedic Laboratory, Massachusetts General Hospital, Harvard Medical School,, International Consortium for Health Outcomes Measurement, Boston, MA, 4ICHOM, International Consortium for Health Outcomes Measurement, Cambridge, MA, 514 Arrow St., Ste. #11, 3International Consortium for Health Outcomes Measurement, Cambridge, MA, 6Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Clinical practice and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Osteoarthritis - Clinical Aspects Poster II: Biomarkers, Biomechanics and Health Services Research

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: To define a minimum Standard Set of outcome measures and case-mix factors for monitoring, comparing, and improving healthcare for patients with clinically diagnosed hip or knee osteoarthritis (OA) with a focus on defining the outcomes that matter most to patients.

Methods:  An international Working Group (WG) of patients, arthroplasty register experts, orthopedic surgeons, primary care physicians, rheumatologists, and physical therapists representing 10 countries was assembled to review existing literature and practices for assessing outcomes of pharmacological and non-pharmacological OA therapies including surgery. A series of 8 teleconferences, incorporating a modified Delphi process, were held to reach consensus.

Results: The WG reached consensus on a concise set of outcomes measures to evaluate patients’ joint pain, physical functioning, health-related quality of life, work status, mortality, reoperations, readmissions, and overall satisfaction with treatment result. To support analysis of these outcome measures, pertinent baseline characteristics and risk factor metrics were defined (see Table 1). Annual outcome measurement is recommended for all patients.

Conclusion: We have defined a Standard Set of outcome measures for monitoring the care of people with clinically diagnosed hip and knee OA that is appropriate for use across in all treatment and care settings. We believe this Standard Set provides meaningful, comparable, and easy to interpret measures ready to implement in clinics and/or registries globally. We view this as an initial step that, when combined with cost data, will facilitate value-based healthcare improvements in the treatment of hip and knee OA.  

Outcome Domains

Risk Factor Domains

Patient reported

  • Hip and/or knee function (HOOS-PS or KOOS-PS)
  • Pain in the hips, knees or lower back (Numeric or visual analog rating scale)
  • Quality of life (EQ-5D-3L or VR-12/SF-12)
  • Satisfaction with treatment
  • Work status

Surgical outcomes

  • All cause 30-day mortality
  • All cause 30-day readmissions
  • Reoperation

Disease progression

  • Care utilization
  • Treatment progression

Demographics

  • Age
  • Gender
  • Education level

Baseline clinical status

  • Joint specific history
  • Joint specific surgical history

Case-mix factors

  • Living status
  • BMI
  • Smoking status
  • Co-morbid conditions

Disclosure: P. G. Conaghan, Abbvie, BMS, Novartis Non-remunerative, 5,Abbvie, BMS, Janssen, Roche, 8; L. March, None; O. Rolfson, None; S. Wissig, None; C. Stowell, None; P. D. Franklin, None.

To cite this abstract in AMA style:

Conaghan PG, March L, Rolfson O, Wissig S, Stowell C, Franklin PD. Report from the International Consortium of Health Outcome Measurement Hip and Knee Osteoarthritis Working Group: Consensus on an International Standard Set of Outcomes Measures for Patients with Hip or Knee Osteoarthritis. [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/report-from-the-international-consortium-of-health-outcome-measurement-hip-and-knee-osteoarthritis-working-group-consensus-on-an-international-standard-set-of-outcomes-measures-for-patients-with-hip/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/report-from-the-international-consortium-of-health-outcome-measurement-hip-and-knee-osteoarthritis-working-group-consensus-on-an-international-standard-set-of-outcomes-measures-for-patients-with-hip/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology